Ou Yen-Chuan, Hung Sheng-Chun, Hwang Li-Hua, Yang Chun-Kuang, Hung Siu-Wan, Tung Min-Che
Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
Department of Research, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
Anticancer Res. 2017 Apr;37(4):2045-2050. doi: 10.21873/anticanres.11550.
To report the outcomes of salvage robot-assisted radical prostatectomy (S-RaRP).
Fourteen patients underwent S-RaRP. The mean initial prostatic-specific antigen level was 14.3 ng/ml and mean Gleason score was 6.93. Initial definitive treatment was external irradiation in 11 cases, cyberknife in two, and high-intensity focused ultrasound in one. Time from definitive treatment to S-RaRP was a mean of 36.5 months.
The mean console time was 134.9 min and blood loss was 99.6 ml. Stage pT2N0, T3N0, and T3N1 were found in eight, four, and two cases, respectively. A positive surgical margin was found in 21.4% (3/14) of the patients. The continence rate was 71.4% (10/14). Mild stress urinary incontinence (one or two pads/day) was noted in 28.6% (4/14) of patients. Biochemical recurrence-free status was noted in 11 (78.5%) patients with a mean follow-up of 32.4 months.
S-RaRP is feasible with a low complication rate, good continence rate, and an acceptable potency rate. The short-term oncological outcomes are encouraging.
报告挽救性机器人辅助根治性前列腺切除术（S-RaRP）的结果。
14例患者接受了S-RaRP。初始前列腺特异性抗原平均水平为14.3 ng/ml，Gleason评分平均为6.93。初始确定性治疗中，11例为体外照射，2例为射波刀治疗，1例为高强度聚焦超声治疗。从确定性治疗到S-RaRP的时间平均为36.5个月。
平均控制台操作时间为134.9分钟，失血量为99.6毫升。分别有8例、4例和2例患者病理分期为pT2N0、T3N0和T3N1。21.4%（3/14）的患者切缘阳性。控尿率为71.4%（10/14）。28.6%（4/14）的患者出现轻度压力性尿失禁（每天使用1或2片尿垫）。11例（78.5%）患者生化无复发生存状态良好，平均随访32.4个月。
S-RaRP可行，并发症发生率低，控尿率良好，性功能保留率可接受。短期肿瘤学结果令人鼓舞。
